from Health Economics and Genomics at https://bit.ly/319wjGz on November 30, 2021 at 11:03PM One publication from the past week: Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care | link I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates […]
from The Incidental Economist at https://bit.ly/3DlYRcZ on November 30, 2021 at 10:09PM There’s a lot of talk about “natural immunity” to Covid-19, and some people are refusing vaccination on the grounds that they’ve got this natural immunity thanks to a previous Covid-19 infection. In this episode we take a look at how infection and vaccination […]
from Google Alert at https://bit.ly/3D9ZXYX on November 30, 2021 at 09:14PM … eliminated,” Manuela Di Fusco, lead study author from the Pfizer Health Economics and Outcomes Research team, said in a news release.
from The Health Care Blog at https://bit.ly/3EcmaH5 on November 30, 2021 at 07:51PM By JESSICA DaMASSA, WTF HEALTH Healthcare navigator Accolade (NASDAQ:ACCD) is on the move. Not only are they now cruising in care delivery territory with two new primary care/mental healthcare offerings that let them personally guide their 9M members further into the healthcare […]
from Google Alert at https://bit.ly/31j1T4l on November 30, 2021 at 05:59PM … in fully vaccinated people is not completely eliminated," said Di Fusco, director of health economics and outcomes research at Pfizer.
from Google Alert at https://bit.ly/3oa66Ao on November 30, 2021 at 05:59PM In a collaboration with songwriter [Maja Vasilj|https://bit.ly/32MGn8N] (Nashville), [Natalie Nicole Gilbert|https://natalienicolegilbert.com] …
from Google Alert at https://bit.ly/3d4nKPG on November 30, 2021 at 05:59PM Journal of Health Economics. Retrieved from https://bit.ly/3FXWbUo. Miguel, Edward, Satyanath, Shanker, and Ernest Sergenti, …
from The Health Care Blog at https://bit.ly/3IaAlPl on November 30, 2021 at 05:50PM Today on Health in 2 Point 00, Jess and I talk about the FDA informing Owlet, whose CEO Jess interviewed about their products and business model, that they can no longer sell their socks. EasyHealth, a medicare advantage broker, gets 35 million […]
from Edinburgh Health Economics at https://bit.ly/3D2EjWE on November 30, 2021 at 04:47PM Last month (8-12 November), the Scottish Bowel Cancer Intelligence UK team at Edinburgh Health Economics attended the National Cancer Research Institute (NCRI) Festival: Making cancer research better together, with a poster on their recent work “Early colorectal cancer treatment and outcomes in Scotland: […]
from RAND Research Topic: Health and Health Care at https://bit.ly/3I4GLiZ on November 30, 2021 at 04:12PM Public anxiety and fear during the pandemic and negative rhetoric by politicians triggered the current wave of anti-Asian hate. It has galvanized the community to build newfound alliances and resilience. Advocates are working to increase reporting of hate incidents […]
from RAND Research Topic: Health and Health Care at https://bit.ly/3pfMA4I on November 30, 2021 at 04:12PM We analyzed data from active component service members in the 2018 Health Related Behaviors Survey. Findings can help inform behavior change interventions to improve psychological fitness and military readiness.
from Google Alert at https://bit.ly/3d1Pc0e on November 30, 2021 at 02:51PM PhD in Public Health, Epidemiology, Demography, Health Economics, or any related field. · Experience in conducting program evaluations, …
from Google Alert at https://bit.ly/31f6vbq on November 30, 2021 at 02:51PM … the immunocompromised individuals,” said Manuela Di Fusco, study lead author from the Pfizer Health Economics and Outcomes Research team.
from Google Alert at https://bit.ly/3DkxfF7 on November 30, 2021 at 02:51PM … and Outcomes Research (ISPOR) Europe 2021 virtual meeting. ISPOR is a leading professional society for health economics and outcomes research.
from Google Alert at https://bit.ly/3xHntLN on November 30, 2021 at 02:51PM Manuela Di Fusco, Study Lead Author, Pfizer Health Economics and Outcomes Research team, Taylor & Francis Group. "Several countries are currently …
from Google Alert at https://bit.ly/3daiyJL on November 30, 2021 at 02:51PM ISPOR is a leading professional society for health economics and outcomes research. "In addition to the strong clinical efficacy that has already …
from Market Design at https://bit.ly/3o4r4Av on November 30, 2021 at 01:27PM Here’s a short interview with Ido Erev, the great behavioral scientist from whom I learned a lot about learning: Interview with Ido Erev Here is his closing comment: "When I started studying the effect of experience, in the 90s, I asked several famous researchers […]
from The Health Care Blog at https://bit.ly/3d3AlCt on November 30, 2021 at 01:10PM By KIM BELLARD It has been said that if your company has a Chief Innovation Officer or an Innovation Department, it’s probably not a very innovative company. To be successful, innovation has to be part of a company’s culture, embraced widely, and […]
from AcademyHealth Blog at https://bit.ly/3o93dzL on November 30, 2021 at 12:44PM 2021 Reinhardt Lecture Discusses Prices as Signals Dr. Uwe Reinhardt was famous for quipping, and writing, “it’s the prices, stupid.” Although I’d never let my own children use the pejorative term, there’s much to admire about the sheer simplicity of the message. If you […]
from Google Alert at https://bit.ly/3d5uGf7 on November 30, 2021 at 11:45AM The health economics and outcomes research (HEOR) services market in Europe is expected to grow from US$ 493.2 million in 2020 to US$ 1,107.1 …
from Google Alert at https://bit.ly/3oeTo3n on November 30, 2021 at 11:45AM The report contains a thorough summary of Europe Health Economics and Outcomes Research (HEOR) Services Market that includes several well-known …
from Google Alert at https://bit.ly/3pbZLDM on November 30, 2021 at 11:45AM … among the immunocompromised individuals”—states Manuela Di Fusco, lead author from the Pfizer Health Economics and Outcomes Research team.
from Google Alert at https://bit.ly/3xAMSa7 on November 30, 2021 at 08:30AM … among the …
from Google Alert at https://bit.ly/3I62k2B on November 30, 2021 at 08:30AM … among the immunocompromised individuals," said Manuela Di Fusco, lead author from the Pfizer Health Economics and Outcomes Research team.
from Google Alert at https://bit.ly/3E7paEX on November 30, 2021 at 08:30AM Jared Streatfeild, associate director of health economics and social policy at Deloitte Access Economics, says they arrived at the number using …
from Google Alert at https://bit.ly/3d4LtyU on November 30, 2021 at 08:10AM The World Health Organisation, in the shape of the Council on the Economics of Health for All, believed in some fundamental truths: that health …
from Healthcare Economist at https://bit.ly/3pgtqf7 on November 30, 2021 at 05:12AM Specialty drugs have delivered significant improvements to patient health, but oftentimes they pay be expensive. To try to insure that these treatments are used appropriately, some health plans impose a utilization management tool known as “prescriber requirements” where only certain types of physicians may […]
from Australian Health Economics Society at https://bit.ly/3xBs9ml on November 30, 2021 at 03:24AM Deakin Health Economics (DHE) has published the third edition of their bi-annual newsletter, which is available to browse here. The newsletter will have information about the latest research and activities the DHE research team is involved in. The post Deakin Health Economics […]
from Google Alert at https://bit.ly/3EiL9IM on November 30, 2021 at 02:16AM … FNCE 002: Essentials of Personal Finance · STAT 001: Introduction to Statistics and Data Science · HCMG 001: Introduction to Health Economics …
from Google Alert at https://bit.ly/3CZY69a on November 30, 2021 at 02:16AM … areas of behavioral health, health services, health disparities, health policy, health economics, pharmacoepidemiology, and aging research.
from The Health Care Blog at https://bit.ly/3peWDH2 on November 30, 2021 at 12:17AM Each week I’ve been adding a brief tidbits section to the THCB Reader, our weekly newsletter that summarizes the best of THCB that week (Sign up here!). Then I had the brainwave to add them to the blog. They’re short and usually […]
from Healthcare Economist at https://bit.ly/3dhJBmR on November 30, 2021 at 12:14AM Last month, the Government Accountability Office released a report on the cost of rare disease. The report is interesting, and especially interesting is Appendix 1 which has a detailed list of studies of the cost of rare disease for about 50 rare diseases. Below […]
from Google Alert at https://bit.ly/31fLZaV on November 29, 2021 at 11:25PM Dr. Feigl-Ding is an epidemiologist, health economist and Senior Fellow at the Federation of American Scientists in Washington DC as well as the …
from Google Alert at https://bit.ly/3D3Gnxx on November 29, 2021 at 11:07PM Health & Veritas: Health Economics · Jason Abaluck, Howard P. Forman, Harlan M. Krumholz. Men in Bangladesh wearing a masks provided as part of a …
from Google Alert at https://bit.ly/3xOQt4B on November 29, 2021 at 11:07PM Asia Pacific Health Economics and Outcomes Research (HEOR) Services Market, COVID-19 Impact, Business Opportunities, Strategies, …
from Google Alert at https://bit.ly/3dhC0Vn on November 29, 2021 at 11:07PM Press release – Business Market Insights – Europe Health Economics And Outcomes Research Heor Services Market To Generate Revenue Of US$ 1107.1 …
from Google Alert at https://bit.ly/3rhIagg on November 29, 2021 at 11:07PM … числе клиник Saint Charles, Bandung, Planetree International, The Canberra Hospital, Centre for Health Economics, VBHC Center Europe, и др.
from Brookings: Topics – Health at https://brook.gs/3nYUYGd on November 29, 2021 at 05:42PM By Samantha Lai The COVID-19 pandemic has facilitated the unprecedented growth of telehealth, with a 78-times increase in use from February 2020 to April 2021. And even as widespread vaccination of the American public has lowered the risk for people to go […]
from Health Economics and Decision Science Blog @ ScHARR at https://bit.ly/3E6nlIi on November 29, 2021 at 03:49PM ScHARR HEDS are back for Virtual ISPOR Europe 2021. From 30 November – 3 December (with on-demand sessions from 22 November), HEDS staff will be attending the latest ISPOR conference to present their work and represent ScHARR. • Professor Paul […]
from The Incidental Economist at https://bit.ly/3o1BLDJ on November 29, 2021 at 03:40PM Over at SCOTUSblog, I’ve written a case preview for American Hospital Association v. Becerra, which is being argued tomorrow. The case is not only important for what it could mean for administrative law. It’s important in its own right because billions of dollars […]
Health Econ Bot 
You must be logged in to post a comment.